Industry: Heart failure monitoring

In a field where available technology is either too expensive or simply ineffective, RePredix is simplifying the monitoring of indicators of heart failure. 

The company is developing an acuity algorithm to successfully predict and warn patients of potential heart failure. Its initial algorithm proved that heart failure can be diagnosed using wristband data. 

Roughly 1 million hospitalizations due to heart failure (HF) each year cost over $31 billion, and around 25% are followed by readmission within 30 days. 

A partnership with LifeQ will assist with hardware development and HIPAA compliant storage of health information.

Back to companies